Literature DB >> 2370567

Performance of concurrent non-motor tasks in Parkinson's disease.

G Goldenberg1.   

Abstract

The purpose of the study was to examine the hypothesis that patients with Parkinson's disease have a general inability to cope with concurrent task demands, and that this inability stems from a lack of attentional control of motor and cognitive activities. Performance on a verbal and on a visuospatial memory task was compared with performance on largely identical memory tasks which were combined with concurrent non-motor tasks. As a further index of a possible weakness of the attentional control of cognitive function order memory was assessed and compared with item memory. Both parkinsonian patients and controls showed a decline of memory performance when the concurrent task was introduced, but the degree of decline did not differ between groups. Parkinsonian patients scored worse than controls on both conditions of the verbal memory task and had more intrusions from previous lists in the verbal single task. There was no significant difference between groups in either item or order memory, but in parkinsonians the scores on order memory decreased with advancing illness. It is concluded that patients with Parkinson's disease do not have a general inability to cope with concurrent task demands, but that the results can be interpreted as indicating a weakness of certain aspects of the attentional control of cognitive function.

Entities:  

Mesh:

Year:  1990        PMID: 2370567     DOI: 10.1007/bf00314593

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Dissociation of item and order spatial memory in rats following medial prefrontal cortex lesions.

Authors:  R P Kesner; T Holbrook
Journal:  Neuropsychologia       Date:  1987       Impact factor: 3.139

2.  Parkinsonism: alterations in spatial orientation as determined by a route-walking test.

Authors:  F P Bowen; M M Hoehn; M D Yahr
Journal:  Neuropsychologia       Date:  1972-09       Impact factor: 3.139

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Memory impairment following ruptured aneurysm of the anterior communicating artery.

Authors:  A J Parkin; N R Leng; N Stanhope; A P Smith
Journal:  Brain Cogn       Date:  1988-04       Impact factor: 2.310

5.  Internal versus external cues and the control of attention in Parkinson's disease.

Authors:  R G Brown; C D Marsden
Journal:  Brain       Date:  1988-04       Impact factor: 13.501

6.  The fractionation of retrograde amnesia.

Authors:  E K Warrington; R A McCarthy
Journal:  Brain Cogn       Date:  1988-04       Impact factor: 2.310

7.  Psychometric differentiation of mild senile dementia of the Alzheimer type.

Authors:  M Storandt; J Botwinick; W L Danziger; L Berg; C P Hughes
Journal:  Arch Neurol       Date:  1984-05

8.  Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

Authors:  F Boller; T Mizutani; U Roessmann; P Gambetti
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

9.  Disturbance of sequential movements in patients with Parkinson's disease.

Authors:  R Benecke; J C Rothwell; J P Dick; B L Day; C D Marsden
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

Review 10.  The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease.

Authors:  H Spinnler; S Della Sala
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

View more
  2 in total

1.  Cerebral correlates of disturbed executive function and memory in survivors of severe closed head injury: a SPECT study.

Authors:  G Goldenberg; W Oder; J Spatt; I Podreka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

Review 2.  MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.

Authors:  Ahmad R Arshad; Siti A Sulaiman; Amalia A Saperi; Rahman Jamal; Norlinah Mohamed Ibrahim; Nor Azian Abdul Murad
Journal:  Front Mol Neurosci       Date:  2017-10-31       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.